Pharmacists must document how the patient meets the eligibility criteria for this policy and use an appropriate assessment and prescribing tool.
If the patient assessment results in identification of risk factors for complicated infection, or the need for urine culture and sensitivity/urinalysis prior to initiating drug therapy, the patient should be referred, and this should be documented.
The assessment and prescribing tool must be used to document the following (as applicable):
- Patient, legal guardian, substitute decision maker consent
- Patient assessment
- Treatment plan, including:
- Prescription(s)
- Specific instructions for use for over-the-counter products
- Follow-up plan
- Referral
- Notification of the patient’s physician or nurse practitioner when one exists. If one does not exist, the pharmacist will document that they have provided the patient with a copy of this notification.
- Completed follow-up information.